fanta.bio Sample: CNhs12239
10640 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2923 / 13831 (21.1%) | 2488 / 138310 (1.8%) | −324.0 | −324.0 | 11.75 |
| Eomes SRX4904815 | Natural killer cells Blood | 3685 / 13831 (26.6%) | 3457 / 138310 (2.5%) | −324.0 | −324.0 | 10.66 |
| Epitope tags SRX13233372 | Testis Gonad | 1326 / 13831 (9.6%) | 1264 / 138310 (0.9%) | −324.0 | −324.0 | 10.49 |
| Tead4 SRX3459538 | Liver Liver | 789 / 13831 (5.7%) | 1002 / 138310 (0.7%) | −324.0 | −324.0 | 7.87 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1040 / 13831 (7.5%) | 1695 / 138310 (1.2%) | −324.0 | −324.0 | 6.14 |
| Rag1 SRX1046534 | Thymocytes Blood | 1293 / 13831 (9.3%) | 2393 / 138310 (1.7%) | −324.0 | −324.0 | 5.40 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1214 / 13831 (8.8%) | 2254 / 138310 (1.6%) | −324.0 | −324.0 | 5.39 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1040 / 13831 (7.5%) | 1943 / 138310 (1.4%) | −324.0 | −324.0 | 5.35 |
| Med1 SRX206369 | Pro-B cells Blood | 1239 / 13831 (9.0%) | 2339 / 138310 (1.7%) | −324.0 | −324.0 | 5.30 |
| Brd4 SRX1465788 | B cells Blood | 1373 / 13831 (9.9%) | 2713 / 138310 (2.0%) | −324.0 | −324.0 | 5.06 |
| Rag2 SRX018809 | Thymocytes Blood | 1188 / 13831 (8.6%) | 2364 / 138310 (1.7%) | −324.0 | −324.0 | 5.03 |
| Ets1 SRX1881673 | B cells Blood | 1191 / 13831 (8.6%) | 2407 / 138310 (1.7%) | −324.0 | −324.0 | 4.95 |
| Ets1 SRX1881674 | B cells Blood | 1163 / 13831 (8.4%) | 2363 / 138310 (1.7%) | −324.0 | −324.0 | 4.92 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1137 / 13831 (8.2%) | 2317 / 138310 (1.7%) | −324.0 | −324.0 | 4.91 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1139 / 13831 (8.2%) | 2333 / 138310 (1.7%) | −324.0 | −324.0 | 4.88 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1557 / 13831 (11.3%) | 3302 / 138310 (2.4%) | −324.0 | −324.0 | 4.72 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1153 / 13831 (8.3%) | 2451 / 138310 (1.8%) | −324.0 | −324.0 | 4.70 |
| Nipbl SRX5730170 | B cells Blood | 1132 / 13831 (8.2%) | 2407 / 138310 (1.7%) | −324.0 | −324.0 | 4.70 |
| Epitope tags SRX3279733 | B cells Blood | 1538 / 13831 (11.1%) | 3357 / 138310 (2.4%) | −324.0 | −324.0 | 4.58 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1187 / 13831 (8.6%) | 2627 / 138310 (1.9%) | −324.0 | −324.0 | 4.52 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1249 / 13831 (9.0%) | 2771 / 138310 (2.0%) | −324.0 | −324.0 | 4.51 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1347 / 13831 (9.7%) | 3023 / 138310 (2.2%) | −324.0 | −324.0 | 4.46 |
| Kmt2a SRX17605412 | Leukemia Blood | 1426 / 13831 (10.3%) | 3204 / 138310 (2.3%) | −324.0 | −324.0 | 4.45 |
| Rag2 SRX1046543 | Thymocytes Blood | 1970 / 13831 (14.2%) | 4476 / 138310 (3.2%) | −324.0 | −324.0 | 4.40 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1241 / 13831 (9.0%) | 2824 / 138310 (2.0%) | −324.0 | −324.0 | 4.39 |
| Epitope tags SRX3219118 | RN2 Blood | 1378 / 13831 (10.0%) | 3139 / 138310 (2.3%) | −324.0 | −324.0 | 4.39 |
| Med12 SRX5086066 | Th2 Cells Blood | 1417 / 13831 (10.2%) | 3229 / 138310 (2.3%) | −324.0 | −324.0 | 4.39 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1223 / 13831 (8.8%) | 2797 / 138310 (2.0%) | −324.0 | −324.0 | 4.37 |
| Myc SRX5356999 | Naive B cells Blood | 1362 / 13831 (9.8%) | 3117 / 138310 (2.3%) | −324.0 | −324.0 | 4.37 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1223 / 13831 (8.8%) | 2800 / 138310 (2.0%) | −324.0 | −324.0 | 4.37 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1209 / 13831 (8.7%) | 2786 / 138310 (2.0%) | −324.0 | −324.0 | 4.34 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1289 / 13831 (9.3%) | 3024 / 138310 (2.2%) | −324.0 | −324.0 | 4.26 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3035 / 13831 (21.9%) | 7158 / 138310 (5.2%) | −324.0 | −324.0 | 4.24 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1513 / 13831 (10.9%) | 3585 / 138310 (2.6%) | −324.0 | −324.0 | 4.22 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1465 / 13831 (10.6%) | 3481 / 138310 (2.5%) | −324.0 | −324.0 | 4.21 |
| Nipbl SRX5730166 | B cells Blood | 1512 / 13831 (10.9%) | 3601 / 138310 (2.6%) | −324.0 | −324.0 | 4.20 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1372 / 13831 (9.9%) | 3269 / 138310 (2.4%) | −324.0 | −324.0 | 4.20 |
| Erg SRX310200 | Mast Cells Blood | 1422 / 13831 (10.3%) | 3403 / 138310 (2.5%) | −324.0 | −324.0 | 4.18 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1550 / 13831 (11.2%) | 3720 / 138310 (2.7%) | −324.0 | −324.0 | 4.17 |
| Brd4 SRX7799914 | CH12 Blood | 1620 / 13831 (11.7%) | 3893 / 138310 (2.8%) | −324.0 | −324.0 | 4.16 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1573 / 13831 (11.4%) | 3787 / 138310 (2.7%) | −324.0 | −324.0 | 4.15 |
| Bcl11b SRX1677234 | Thymus Blood | 1945 / 13831 (14.1%) | 4723 / 138310 (3.4%) | −324.0 | −324.0 | 4.12 |
| Bcor SRX22719795 | Leukemia Blood | 1433 / 13831 (10.4%) | 3480 / 138310 (2.5%) | −324.0 | −324.0 | 4.12 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2015 / 13831 (14.6%) | 4911 / 138310 (3.6%) | −324.0 | −324.0 | 4.10 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1523 / 13831 (11.0%) | 3712 / 138310 (2.7%) | −324.0 | −324.0 | 4.10 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1375 / 13831 (9.9%) | 3359 / 138310 (2.4%) | −324.0 | −324.0 | 4.09 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1286 / 13831 (9.3%) | 3143 / 138310 (2.3%) | −324.0 | −324.0 | 4.09 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1291 / 13831 (9.3%) | 3176 / 138310 (2.3%) | −324.0 | −324.0 | 4.06 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 1807 / 13831 (13.1%) | 4471 / 138310 (3.2%) | −324.0 | −324.0 | 4.04 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 1779 / 13831 (12.9%) | 4414 / 138310 (3.2%) | −324.0 | −324.0 | 4.03 |
| Runx1 SRX1438366 | EML Blood | 2224 / 13831 (16.1%) | 5521 / 138310 (4.0%) | −324.0 | −324.0 | 4.03 |
| Myc SRX5356998 | Naive B cells Blood | 1765 / 13831 (12.8%) | 4389 / 138310 (3.2%) | −324.0 | −324.0 | 4.02 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1535 / 13831 (11.1%) | 3821 / 138310 (2.8%) | −324.0 | −324.0 | 4.02 |
| Bach2 SRX2200546 | Pro-B cells Blood | 1581 / 13831 (11.4%) | 3939 / 138310 (2.8%) | −324.0 | −324.0 | 4.01 |
| Runx1 SRX5358496 | Pro-B cells Blood | 2612 / 13831 (18.9%) | 6520 / 138310 (4.7%) | −324.0 | −324.0 | 4.01 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1498 / 13831 (10.8%) | 3746 / 138310 (2.7%) | −324.0 | −324.0 | 4.00 |
| Myc SRX5357000 | Naive B cells Blood | 1671 / 13831 (12.1%) | 4185 / 138310 (3.0%) | −324.0 | −324.0 | 3.99 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1654 / 13831 (12.0%) | 4146 / 138310 (3.0%) | −324.0 | −324.0 | 3.99 |
| Med12 SRX5086068 | Th2 Cells Blood | 1333 / 13831 (9.6%) | 3343 / 138310 (2.4%) | −324.0 | −324.0 | 3.99 |
| Hdac1 SRX7726758 | B cells Blood | 1424 / 13831 (10.3%) | 3596 / 138310 (2.6%) | −324.0 | −324.0 | 3.96 |
| Nipbl SRX8694069 | B cells Blood | 1439 / 13831 (10.4%) | 3634 / 138310 (2.6%) | −324.0 | −324.0 | 3.96 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 1791 / 13831 (12.9%) | 4527 / 138310 (3.3%) | −324.0 | −324.0 | 3.96 |
| Ets1 SRX5086094 | Th2 Cells Blood | 1967 / 13831 (14.2%) | 4978 / 138310 (3.6%) | −324.0 | −324.0 | 3.95 |
| Epitope tags SRX3279734 | B cells Blood | 2389 / 13831 (17.3%) | 6061 / 138310 (4.4%) | −324.0 | −324.0 | 3.94 |
| Kdm2b SRX22719856 | Leukemia Blood | 1618 / 13831 (11.7%) | 4108 / 138310 (3.0%) | −324.0 | −324.0 | 3.94 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1461 / 13831 (10.6%) | 3729 / 138310 (2.7%) | −324.0 | −324.0 | 3.92 |
| Spi1 SRX1465791 | B cells Blood | 1382 / 13831 (10.0%) | 3542 / 138310 (2.6%) | −324.0 | −324.0 | 3.90 |
| Bcl11b SRX1649982 | Thymus Blood | 2094 / 13831 (15.1%) | 5368 / 138310 (3.9%) | −324.0 | −324.0 | 3.90 |
| Pax5 SRX19312223 | Pro-B cells Blood | 1748 / 13831 (12.6%) | 4487 / 138310 (3.2%) | −324.0 | −324.0 | 3.90 |
| Rag2 SRX1046552 | B cells Blood | 2216 / 13831 (16.0%) | 5703 / 138310 (4.1%) | −324.0 | −324.0 | 3.89 |
| Rag2 SRX1046550 | B cells Blood | 2477 / 13831 (17.9%) | 6379 / 138310 (4.6%) | −324.0 | −324.0 | 3.88 |
| Myc SRX353784 | B cells Blood | 1673 / 13831 (12.1%) | 4316 / 138310 (3.1%) | −324.0 | −324.0 | 3.88 |
| Nipbl SRX4895107 | CH12 Blood | 1566 / 13831 (11.3%) | 4045 / 138310 (2.9%) | −324.0 | −324.0 | 3.87 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2439 / 13831 (17.6%) | 6305 / 138310 (4.6%) | −324.0 | −324.0 | 3.87 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1588 / 13831 (11.5%) | 4108 / 138310 (3.0%) | −324.0 | −324.0 | 3.87 |
| Ep300 SRX25655383 | Leukemia Blood | 1526 / 13831 (11.0%) | 3958 / 138310 (2.9%) | −324.0 | −324.0 | 3.86 |
| Nipbl SRX5730164 | CH12F3 Blood | 1396 / 13831 (10.1%) | 3664 / 138310 (2.6%) | −324.0 | −324.0 | 3.81 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 1651 / 13831 (11.9%) | 4358 / 138310 (3.2%) | −324.0 | −324.0 | 3.79 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 1729 / 13831 (12.5%) | 4564 / 138310 (3.3%) | −324.0 | −324.0 | 3.79 |
| GFP SRX2486160 | C127 Breast | 1435 / 13831 (10.4%) | 3790 / 138310 (2.7%) | −324.0 | −324.0 | 3.79 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1428 / 13831 (10.3%) | 3777 / 138310 (2.7%) | −324.0 | −324.0 | 3.78 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1614 / 13831 (11.7%) | 4273 / 138310 (3.1%) | −324.0 | −324.0 | 3.78 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 1963 / 13831 (14.2%) | 5202 / 138310 (3.8%) | −324.0 | −324.0 | 3.77 |
| Nipbl SRX5730169 | B cells Blood | 1471 / 13831 (10.6%) | 3910 / 138310 (2.8%) | −324.0 | −324.0 | 3.76 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 2785 / 13831 (20.1%) | 7403 / 138310 (5.4%) | −324.0 | −324.0 | 3.76 |
| Ets1 SRX5086099 | Th2 Cells Blood | 1858 / 13831 (13.4%) | 4944 / 138310 (3.6%) | −324.0 | −324.0 | 3.76 |
| Bcl11b SRX1677239 | Thymus Blood | 2034 / 13831 (14.7%) | 5419 / 138310 (3.9%) | −324.0 | −324.0 | 3.75 |
| Myc SRX353783 | B cells Blood | 2185 / 13831 (15.8%) | 5826 / 138310 (4.2%) | −324.0 | −324.0 | 3.75 |
| Pax5 SRX19312225 | Pro-B cells Blood | 1781 / 13831 (12.9%) | 4760 / 138310 (3.4%) | −324.0 | −324.0 | 3.74 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1530 / 13831 (11.1%) | 4095 / 138310 (3.0%) | −324.0 | −324.0 | 3.74 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2078 / 13831 (15.0%) | 5574 / 138310 (4.0%) | −324.0 | −324.0 | 3.73 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 1696 / 13831 (12.3%) | 4561 / 138310 (3.3%) | −324.0 | −324.0 | 3.72 |
| Runx3 SRX8718717 | T progenitor cells Blood | 1971 / 13831 (14.3%) | 5303 / 138310 (3.8%) | −324.0 | −324.0 | 3.72 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1484 / 13831 (10.7%) | 3994 / 138310 (2.9%) | −324.0 | −324.0 | 3.72 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 1696 / 13831 (12.3%) | 4566 / 138310 (3.3%) | −324.0 | −324.0 | 3.71 |
| Nelfe SRX140395 | MEL Blood | 1476 / 13831 (10.7%) | 3974 / 138310 (2.9%) | −324.0 | −324.0 | 3.71 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1443 / 13831 (10.4%) | 3888 / 138310 (2.8%) | −324.0 | −324.0 | 3.71 |
| Rag2 SRX1046542 | Thymocytes Blood | 2535 / 13831 (18.3%) | 6846 / 138310 (4.9%) | −324.0 | −324.0 | 3.70 |
| Nipbl SRX8694067 | B cells Blood | 1488 / 13831 (10.8%) | 4036 / 138310 (2.9%) | −324.0 | −324.0 | 3.69 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2216 / 13831 (16.0%) | 6012 / 138310 (4.3%) | −324.0 | −324.0 | 3.69 |
| Runx1 SRX1438367 | EML Blood | 2504 / 13831 (18.1%) | 6831 / 138310 (4.9%) | −324.0 | −324.0 | 3.67 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2079 / 13831 (15.0%) | 5676 / 138310 (4.1%) | −324.0 | −324.0 | 3.66 |
| Myc SRX353785 | B cells Blood | 2177 / 13831 (15.7%) | 5952 / 138310 (4.3%) | −324.0 | −324.0 | 3.66 |
| Nipbl SRX8694065 | B cells Blood | 1933 / 13831 (14.0%) | 5297 / 138310 (3.8%) | −324.0 | −324.0 | 3.65 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2187 / 13831 (15.8%) | 5995 / 138310 (4.3%) | −324.0 | −324.0 | 3.65 |
| Nipbl SRX5730171 | B cells Blood | 1486 / 13831 (10.7%) | 4074 / 138310 (2.9%) | −324.0 | −324.0 | 3.65 |
| Bcor SRX22719796 | Leukemia Blood | 1946 / 13831 (14.1%) | 5341 / 138310 (3.9%) | −324.0 | −324.0 | 3.64 |
| Men1 SRX415267 | Th2 Cells Blood | 1446 / 13831 (10.5%) | 3971 / 138310 (2.9%) | −324.0 | −324.0 | 3.64 |
| Rag2 SRX1046541 | Thymocytes Blood | 2653 / 13831 (19.2%) | 7311 / 138310 (5.3%) | −324.0 | −324.0 | 3.63 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2422 / 13831 (17.5%) | 6683 / 138310 (4.8%) | −324.0 | −324.0 | 3.62 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2476 / 13831 (17.9%) | 6833 / 138310 (4.9%) | −324.0 | −324.0 | 3.62 |
| Kmt2a SRX17605411 | Leukemia Blood | 2108 / 13831 (15.2%) | 5821 / 138310 (4.2%) | −324.0 | −324.0 | 3.62 |
| Nipbl SRX8694063 | T cells Blood | 1920 / 13831 (13.9%) | 5302 / 138310 (3.8%) | −324.0 | −324.0 | 3.62 |
| Crebbp SRX25655381 | Leukemia Blood | 1835 / 13831 (13.3%) | 5081 / 138310 (3.7%) | −324.0 | −324.0 | 3.61 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 1742 / 13831 (12.6%) | 4824 / 138310 (3.5%) | −324.0 | −324.0 | 3.61 |
| Brd4 SRX7799919 | CH12 Blood | 2069 / 13831 (15.0%) | 5731 / 138310 (4.1%) | −324.0 | −324.0 | 3.61 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2441 / 13831 (17.6%) | 6783 / 138310 (4.9%) | −324.0 | −324.0 | 3.60 |
| Nipbl SRX3753617 | B cells Blood | 1917 / 13831 (13.9%) | 5335 / 138310 (3.9%) | −324.0 | −324.0 | 3.59 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2146 / 13831 (15.5%) | 5975 / 138310 (4.3%) | −324.0 | −324.0 | 3.59 |
| Bach2 SRX2200545 | Pro-B cells Blood | 1741 / 13831 (12.6%) | 4858 / 138310 (3.5%) | −324.0 | −324.0 | 3.58 |
| Nipbl SRX4895127 | CH12 Blood | 2321 / 13831 (16.8%) | 6488 / 138310 (4.7%) | −324.0 | −324.0 | 3.58 |
| Spi1 SRX5026214 | Mast Cells Blood | 1483 / 13831 (10.7%) | 4147 / 138310 (3.0%) | −324.0 | −324.0 | 3.58 |
| Cbfb SRX2389673 | Thymocytes Blood | 1986 / 13831 (14.4%) | 5561 / 138310 (4.0%) | −324.0 | −324.0 | 3.57 |
| GFP SRX2486159 | C127 Breast | 1749 / 13831 (12.6%) | 4921 / 138310 (3.6%) | −324.0 | −324.0 | 3.55 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 1896 / 13831 (13.7%) | 5347 / 138310 (3.9%) | −324.0 | −324.0 | 3.55 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 1947 / 13831 (14.1%) | 5492 / 138310 (4.0%) | −324.0 | −324.0 | 3.55 |
| Kdm2b SRX22719855 | Leukemia Blood | 2113 / 13831 (15.3%) | 5974 / 138310 (4.3%) | −324.0 | −324.0 | 3.54 |
| Wdr5 SRX1815529 | B cells Blood | 1690 / 13831 (12.2%) | 4788 / 138310 (3.5%) | −324.0 | −324.0 | 3.53 |
| Runx1 SRX5358492 | Pro-B cells Blood | 2955 / 13831 (21.4%) | 8382 / 138310 (6.1%) | −324.0 | −324.0 | 3.53 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2064 / 13831 (14.9%) | 5855 / 138310 (4.2%) | −324.0 | −324.0 | 3.53 |
| Fli1 SRX310201 | Mast Cells Blood | 1806 / 13831 (13.1%) | 5125 / 138310 (3.7%) | −324.0 | −324.0 | 3.52 |
| Rag2 SRX1046545 | Thymocytes Blood | 2752 / 13831 (19.9%) | 7810 / 138310 (5.6%) | −324.0 | −324.0 | 3.52 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2294 / 13831 (16.6%) | 6524 / 138310 (4.7%) | −324.0 | −324.0 | 3.52 |
| Runx1 SRX5358488 | Pro-B cells Blood | 1777 / 13831 (12.8%) | 5065 / 138310 (3.7%) | −324.0 | −324.0 | 3.51 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1651 / 13831 (11.9%) | 4712 / 138310 (3.4%) | −324.0 | −324.0 | 3.50 |
| Spi1 SRX5026215 | Mast Cells Blood | 1530 / 13831 (11.1%) | 4369 / 138310 (3.2%) | −324.0 | −324.0 | 3.50 |
| Bcl11b SRX18851328 | Thymocytes Blood | 1987 / 13831 (14.4%) | 5694 / 138310 (4.1%) | −324.0 | −324.0 | 3.49 |
| Hdac1 SRX7726755 | B cells Blood | 1663 / 13831 (12.0%) | 4769 / 138310 (3.4%) | −324.0 | −324.0 | 3.49 |
| Bcor SRX22719813 | Leukemia Blood | 1589 / 13831 (11.5%) | 4593 / 138310 (3.3%) | −324.0 | −324.0 | 3.46 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1692 / 13831 (12.2%) | 4891 / 138310 (3.5%) | −324.0 | −324.0 | 3.46 |
| Rag2 SRX1046553 | B cells Blood | 2745 / 13831 (19.8%) | 7943 / 138310 (5.7%) | −324.0 | −324.0 | 3.46 |
| Med26 SRX20509320 | CH12 Blood | 1823 / 13831 (13.2%) | 5282 / 138310 (3.8%) | −324.0 | −324.0 | 3.45 |
| Nipbl SRX2755276 | B cells Blood | 2142 / 13831 (15.5%) | 6207 / 138310 (4.5%) | −324.0 | −324.0 | 3.45 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1622 / 13831 (11.7%) | 4704 / 138310 (3.4%) | −324.0 | −324.0 | 3.45 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 1725 / 13831 (12.5%) | 5043 / 138310 (3.6%) | −324.0 | −324.0 | 3.42 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3089 / 13831 (22.3%) | 9056 / 138310 (6.5%) | −324.0 | −324.0 | 3.41 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2241 / 13831 (16.2%) | 6597 / 138310 (4.8%) | −324.0 | −324.0 | 3.40 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2438 / 13831 (17.6%) | 7191 / 138310 (5.2%) | −324.0 | −324.0 | 3.39 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 1821 / 13831 (13.2%) | 5373 / 138310 (3.9%) | −324.0 | −324.0 | 3.39 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2279 / 13831 (16.5%) | 6727 / 138310 (4.9%) | −324.0 | −324.0 | 3.39 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2404 / 13831 (17.4%) | 7097 / 138310 (5.1%) | −324.0 | −324.0 | 3.39 |
| Rnf2 SRX9633976 | B cells Blood | 1872 / 13831 (13.5%) | 5528 / 138310 (4.0%) | −324.0 | −324.0 | 3.39 |
| Hdac1 SRX9519542 | G1E Blood | 1839 / 13831 (13.3%) | 5431 / 138310 (3.9%) | −324.0 | −324.0 | 3.39 |
| Yy1 SRX14617702 | CH12 Blood | 1636 / 13831 (11.8%) | 4846 / 138310 (3.5%) | −324.0 | −324.0 | 3.38 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 1699 / 13831 (12.3%) | 5046 / 138310 (3.6%) | −324.0 | −324.0 | 3.37 |
| Nipbl SRX2755277 | B cells Blood | 2430 / 13831 (17.6%) | 7239 / 138310 (5.2%) | −324.0 | −324.0 | 3.36 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 1688 / 13831 (12.2%) | 5036 / 138310 (3.6%) | −324.0 | −324.0 | 3.35 |
| Nipbl SRX3753616 | B cells Blood | 2303 / 13831 (16.7%) | 6895 / 138310 (5.0%) | −324.0 | −324.0 | 3.34 |
| Spi1 SRX5026216 | Mast Cells Blood | 1777 / 13831 (12.8%) | 5329 / 138310 (3.9%) | −324.0 | −324.0 | 3.33 |
| Runx3 SRX8718740 | T progenitor cells Blood | 2586 / 13831 (18.7%) | 7775 / 138310 (5.6%) | −324.0 | −324.0 | 3.33 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2246 / 13831 (16.2%) | 6756 / 138310 (4.9%) | −324.0 | −324.0 | 3.32 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2389 / 13831 (17.3%) | 7194 / 138310 (5.2%) | −324.0 | −324.0 | 3.32 |
| Nipbl SRX4895128 | CH12 Blood | 2579 / 13831 (18.6%) | 7768 / 138310 (5.6%) | −324.0 | −324.0 | 3.32 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 1940 / 13831 (14.0%) | 5850 / 138310 (4.2%) | −324.0 | −324.0 | 3.32 |
| Kmt2a SRX1815528 | B cells Blood | 2557 / 13831 (18.5%) | 7716 / 138310 (5.6%) | −324.0 | −324.0 | 3.31 |
| Epitope tags SRX3219123 | RN2 Blood | 2664 / 13831 (19.3%) | 8052 / 138310 (5.8%) | −324.0 | −324.0 | 3.31 |
| Hdac1 SRX1815525 | B cells Blood | 2694 / 13831 (19.5%) | 8144 / 138310 (5.9%) | −324.0 | −324.0 | 3.31 |
| Hdac1 SRX7726756 | B cells Blood | 1797 / 13831 (13.0%) | 5433 / 138310 (3.9%) | −324.0 | −324.0 | 3.31 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 1874 / 13831 (13.5%) | 5694 / 138310 (4.1%) | −324.0 | −324.0 | 3.29 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2419 / 13831 (17.5%) | 7359 / 138310 (5.3%) | −324.0 | −324.0 | 3.29 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3325 / 13831 (24.0%) | 10134 / 138310 (7.3%) | −324.0 | −324.0 | 3.28 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2090 / 13831 (15.1%) | 6384 / 138310 (4.6%) | −324.0 | −324.0 | 3.27 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3038 / 13831 (22.0%) | 9310 / 138310 (6.7%) | −324.0 | −324.0 | 3.26 |
| Rnf2 SRX9633974 | B cells Blood | 2054 / 13831 (14.9%) | 6303 / 138310 (4.6%) | −324.0 | −324.0 | 3.26 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2186 / 13831 (15.8%) | 6711 / 138310 (4.9%) | −324.0 | −324.0 | 3.26 |
| Rnf2 SRX9633975 | B cells Blood | 2247 / 13831 (16.2%) | 6925 / 138310 (5.0%) | −324.0 | −324.0 | 3.24 |
| Nipbl SRX8694064 | T cells Blood | 1983 / 13831 (14.3%) | 6119 / 138310 (4.4%) | −324.0 | −324.0 | 3.24 |
| Hdac1 SRX9519543 | G1E Blood | 2016 / 13831 (14.6%) | 6221 / 138310 (4.5%) | −324.0 | −324.0 | 3.24 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1670 / 13831 (12.1%) | 5155 / 138310 (3.7%) | −324.0 | −324.0 | 3.24 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2087 / 13831 (15.1%) | 6453 / 138310 (4.7%) | −324.0 | −324.0 | 3.23 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2369 / 13831 (17.1%) | 7353 / 138310 (5.3%) | −324.0 | −324.0 | 3.22 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2465 / 13831 (17.8%) | 7659 / 138310 (5.5%) | −324.0 | −324.0 | 3.22 |
| Kmt2a SRX1815514 | B cells Blood | 2656 / 13831 (19.2%) | 8278 / 138310 (6.0%) | −324.0 | −324.0 | 3.21 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 1732 / 13831 (12.5%) | 5406 / 138310 (3.9%) | −324.0 | −324.0 | 3.20 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 1948 / 13831 (14.1%) | 6081 / 138310 (4.4%) | −324.0 | −324.0 | 3.20 |
| Yy1 SRX14617670 | CH12 Blood | 2150 / 13831 (15.5%) | 6723 / 138310 (4.9%) | −324.0 | −324.0 | 3.20 |
| Kdm2b SRX22719876 | Leukemia Blood | 1969 / 13831 (14.2%) | 6197 / 138310 (4.5%) | −324.0 | −324.0 | 3.18 |
| Pax5 SRX10950551 | Pro-B cells Blood | 1925 / 13831 (13.9%) | 6067 / 138310 (4.4%) | −324.0 | −324.0 | 3.17 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2127 / 13831 (15.4%) | 6707 / 138310 (4.8%) | −324.0 | −324.0 | 3.17 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2049 / 13831 (14.8%) | 6473 / 138310 (4.7%) | −324.0 | −324.0 | 3.17 |
| Nipbl SRX4895106 | CH12 Blood | 2493 / 13831 (18.0%) | 7878 / 138310 (5.7%) | −324.0 | −324.0 | 3.16 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 1832 / 13831 (13.2%) | 5798 / 138310 (4.2%) | −324.0 | −324.0 | 3.16 |
| Spi1 SRX5026210 | Mast Cells Blood | 2110 / 13831 (15.3%) | 6682 / 138310 (4.8%) | −324.0 | −324.0 | 3.16 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2113 / 13831 (15.3%) | 6717 / 138310 (4.9%) | −324.0 | −324.0 | 3.15 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 2667 / 13831 (19.3%) | 8488 / 138310 (6.1%) | −324.0 | −324.0 | 3.14 |
| Chd4 SRX1815523 | B cells Blood | 2683 / 13831 (19.4%) | 8547 / 138310 (6.2%) | −324.0 | −324.0 | 3.14 |
| Nipbl SRX3753615 | B cells Blood | 2286 / 13831 (16.5%) | 7283 / 138310 (5.3%) | −324.0 | −324.0 | 3.14 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2108 / 13831 (15.2%) | 6719 / 138310 (4.9%) | −324.0 | −324.0 | 3.14 |
| Cbfb SRX2389674 | Thymocytes Blood | 3068 / 13831 (22.2%) | 9786 / 138310 (7.1%) | −324.0 | −324.0 | 3.14 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3275 / 13831 (23.7%) | 10447 / 138310 (7.6%) | −324.0 | −324.0 | 3.13 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 2711 / 13831 (19.6%) | 8660 / 138310 (6.3%) | −324.0 | −324.0 | 3.13 |
| Yy1 SRX14617672 | CH12 Blood | 2183 / 13831 (15.8%) | 6984 / 138310 (5.0%) | −324.0 | −324.0 | 3.13 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 1969 / 13831 (14.2%) | 6306 / 138310 (4.6%) | −324.0 | −324.0 | 3.12 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2354 / 13831 (17.0%) | 7548 / 138310 (5.5%) | −324.0 | −324.0 | 3.12 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2496 / 13831 (18.0%) | 8013 / 138310 (5.8%) | −324.0 | −324.0 | 3.11 |
| Cbfb SRX2389672 | Thymocytes Blood | 3145 / 13831 (22.7%) | 10106 / 138310 (7.3%) | −324.0 | −324.0 | 3.11 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2670 / 13831 (19.3%) | 8580 / 138310 (6.2%) | −324.0 | −324.0 | 3.11 |
| Satb1 SRX13440924 | Thymus Blood | 2028 / 13831 (14.7%) | 6523 / 138310 (4.7%) | −324.0 | −324.0 | 3.11 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 2917 / 13831 (21.1%) | 9393 / 138310 (6.8%) | −324.0 | −324.0 | 3.11 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 2864 / 13831 (20.7%) | 9235 / 138310 (6.7%) | −324.0 | −324.0 | 3.10 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2172 / 13831 (15.7%) | 7044 / 138310 (5.1%) | −324.0 | −324.0 | 3.08 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 1958 / 13831 (14.2%) | 6376 / 138310 (4.6%) | −324.0 | −324.0 | 3.07 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2388 / 13831 (17.3%) | 7780 / 138310 (5.6%) | −324.0 | −324.0 | 3.07 |
| Hdac2 SRX1815527 | B cells Blood | 2772 / 13831 (20.0%) | 9099 / 138310 (6.6%) | −324.0 | −324.0 | 3.05 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 1818 / 13831 (13.1%) | 5968 / 138310 (4.3%) | −324.0 | −324.0 | 3.05 |
| Yy1 SRX14617701 | CH12 Blood | 2237 / 13831 (16.2%) | 7390 / 138310 (5.3%) | −324.0 | −324.0 | 3.03 |
| Kdm2b SRX22719877 | Leukemia Blood | 2693 / 13831 (19.5%) | 8925 / 138310 (6.5%) | −324.0 | −324.0 | 3.02 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 2825 / 13831 (20.4%) | 9373 / 138310 (6.8%) | −324.0 | −324.0 | 3.01 |
| Yy1 SRX14617700 | CH12 Blood | 2231 / 13831 (16.1%) | 7406 / 138310 (5.4%) | −324.0 | −324.0 | 3.01 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2237 / 13831 (16.2%) | 7443 / 138310 (5.4%) | −324.0 | −324.0 | 3.01 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3252 / 13831 (23.5%) | 10823 / 138310 (7.8%) | −324.0 | −324.0 | 3.00 |
| Yy1 SRX14617671 | CH12 Blood | 2272 / 13831 (16.4%) | 7564 / 138310 (5.5%) | −324.0 | −324.0 | 3.00 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 1890 / 13831 (13.7%) | 6313 / 138310 (4.6%) | −324.0 | −324.0 | 2.99 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2032 / 13831 (14.7%) | 6821 / 138310 (4.9%) | −324.0 | −324.0 | 2.98 |
| Ikzf1 SRX205987 | B cells Blood | 2530 / 13831 (18.3%) | 8532 / 138310 (6.2%) | −324.0 | −324.0 | 2.97 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2498 / 13831 (18.1%) | 8445 / 138310 (6.1%) | −324.0 | −324.0 | 2.96 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2219 / 13831 (16.0%) | 7508 / 138310 (5.4%) | −324.0 | −324.0 | 2.96 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2295 / 13831 (16.6%) | 7779 / 138310 (5.6%) | −324.0 | −324.0 | 2.95 |
| Spi1 SRX2499682 | CD25+ cells Blood | 1992 / 13831 (14.4%) | 6752 / 138310 (4.9%) | −324.0 | −324.0 | 2.95 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2148 / 13831 (15.5%) | 7292 / 138310 (5.3%) | −324.0 | −324.0 | 2.95 |
| Mxi1 SRX140388 | CH12 Blood | 2036 / 13831 (14.7%) | 6914 / 138310 (5.0%) | −324.0 | −324.0 | 2.94 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3294 / 13831 (23.8%) | 11228 / 138310 (8.1%) | −324.0 | −324.0 | 2.93 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2060 / 13831 (14.9%) | 7043 / 138310 (5.1%) | −324.0 | −324.0 | 2.92 |
| Smarca4 SRX1815522 | B cells Blood | 3148 / 13831 (22.8%) | 10764 / 138310 (7.8%) | −324.0 | −324.0 | 2.92 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2503 / 13831 (18.1%) | 8584 / 138310 (6.2%) | −324.0 | −324.0 | 2.92 |
| Ikzf1 SRX205986 | B cells Blood | 2952 / 13831 (21.3%) | 10201 / 138310 (7.4%) | −324.0 | −324.0 | 2.89 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3012 / 13831 (21.8%) | 10461 / 138310 (7.6%) | −324.0 | −324.0 | 2.88 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 2042 / 13831 (14.8%) | 7133 / 138310 (5.2%) | −324.0 | −324.0 | 2.86 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2206 / 13831 (15.9%) | 7749 / 138310 (5.6%) | −324.0 | −324.0 | 2.85 |
| Spi1 SRX2341954 | Hematopoietic Stem Cells Blood | 2100 / 13831 (15.2%) | 7457 / 138310 (5.4%) | −324.0 | −324.0 | 2.82 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2227 / 13831 (16.1%) | 7918 / 138310 (5.7%) | −324.0 | −324.0 | 2.81 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2291 / 13831 (16.6%) | 8165 / 138310 (5.9%) | −324.0 | −324.0 | 2.81 |
| Smarca4 SRX1815508 | B cells Blood | 3171 / 13831 (22.9%) | 11310 / 138310 (8.2%) | −324.0 | −324.0 | 2.80 |
| Sin3a SRX188801 | CH12 Blood | 2294 / 13831 (16.6%) | 8202 / 138310 (5.9%) | −324.0 | −324.0 | 2.80 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2371 / 13831 (17.1%) | 8500 / 138310 (6.1%) | −324.0 | −324.0 | 2.79 |
| Runx1 SRX310206 | Mast Cells Blood | 2878 / 13831 (20.8%) | 10329 / 138310 (7.5%) | −324.0 | −324.0 | 2.79 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2338 / 13831 (16.9%) | 8393 / 138310 (6.1%) | −324.0 | −324.0 | 2.79 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2087 / 13831 (15.1%) | 7492 / 138310 (5.4%) | −324.0 | −324.0 | 2.79 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2298 / 13831 (16.6%) | 8250 / 138310 (6.0%) | −324.0 | −324.0 | 2.79 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2531 / 13831 (18.3%) | 9088 / 138310 (6.6%) | −324.0 | −324.0 | 2.78 |
| Spi1 SRX886478 | B-ALL Blood | 2837 / 13831 (20.5%) | 10239 / 138310 (7.4%) | −324.0 | −324.0 | 2.77 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 2938 / 13831 (21.2%) | 10661 / 138310 (7.7%) | −324.0 | −324.0 | 2.76 |
| Spi1 SRX1056343 | 416B Blood | 2267 / 13831 (16.4%) | 8303 / 138310 (6.0%) | −324.0 | −324.0 | 2.73 |
| Spi1 SRX2188529 | Pro-B cells Blood | 2183 / 13831 (15.8%) | 8021 / 138310 (5.8%) | −324.0 | −324.0 | 2.72 |
| Hdac2 SRX3660759 | CD4 CD8 double negative cells Blood | 2856 / 13831 (20.6%) | 10533 / 138310 (7.6%) | −324.0 | −324.0 | 2.71 |
| Spi1 SRX2499684 | CD25+ cells Blood | 2291 / 13831 (16.6%) | 8458 / 138310 (6.1%) | −324.0 | −324.0 | 2.71 |
| Spi1 SRX2499683 | CD25+ cells Blood | 2274 / 13831 (16.4%) | 8405 / 138310 (6.1%) | −324.0 | −324.0 | 2.71 |
| Epitope tags SRX6370145 | G1E Blood | 2369 / 13831 (17.1%) | 8760 / 138310 (6.3%) | −324.0 | −324.0 | 2.70 |
| Kmt2d SRX17605402 | Leukemia Blood | 2373 / 13831 (17.2%) | 8780 / 138310 (6.3%) | −324.0 | −324.0 | 2.70 |
| Runx1 SRX3660776 | CD4 CD8 double negative cells Blood | 3088 / 13831 (22.3%) | 11426 / 138310 (8.3%) | −324.0 | −324.0 | 2.70 |
| Runx1 SRX3195539 | CD4 CD8 double negative cells Blood | 3084 / 13831 (22.3%) | 11420 / 138310 (8.3%) | −324.0 | −324.0 | 2.70 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 2760 / 13831 (20.0%) | 10226 / 138310 (7.4%) | −324.0 | −324.0 | 2.70 |
| Runx1 SRX3660775 | CD4 CD8 double negative cells Blood | 3144 / 13831 (22.7%) | 11655 / 138310 (8.4%) | −324.0 | −324.0 | 2.70 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2170 / 13831 (15.7%) | 8048 / 138310 (5.8%) | −324.0 | −324.0 | 2.70 |
| Runx1 SRX3195537 | CD4 CD8 double negative cells Blood | 3139 / 13831 (22.7%) | 11667 / 138310 (8.4%) | −324.0 | −324.0 | 2.69 |
| Kdm1a SRX3660771 | CD4 CD8 double negative cells Blood | 2763 / 13831 (20.0%) | 10289 / 138310 (7.4%) | −324.0 | −324.0 | 2.69 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2386 / 13831 (17.3%) | 8904 / 138310 (6.4%) | −324.0 | −324.0 | 2.68 |
| AML1-ETO SRX3491900 | Spleen Spleen | 2162 / 13831 (15.6%) | 8088 / 138310 (5.8%) | −324.0 | −324.0 | 2.67 |
| Chd4 SRX3660752 | CD4 CD8 double negative cells Blood | 2486 / 13831 (18.0%) | 9314 / 138310 (6.7%) | −324.0 | −324.0 | 2.67 |
| Mxi1 SRX140391 | MEL Blood | 2195 / 13831 (15.9%) | 8224 / 138310 (5.9%) | −324.0 | −324.0 | 2.67 |
| Spi1 SRX7368532 | B cells Blood | 2414 / 13831 (17.5%) | 9048 / 138310 (6.5%) | −324.0 | −324.0 | 2.67 |
| Ascl1 SRX8886261 | Lung tumors Lung | 2234 / 13831 (16.2%) | 8374 / 138310 (6.1%) | −324.0 | −324.0 | 2.67 |
| Epitope tags SRX6370147 | G1E Blood | 2298 / 13831 (16.6%) | 8627 / 138310 (6.2%) | −324.0 | −324.0 | 2.66 |
| Bcl11b SRX2399084 | Thymocytes Blood | 3845 / 13831 (27.8%) | 14446 / 138310 (10.4%) | −324.0 | −324.0 | 2.66 |
| Hdac2 SRX1815513 | B cells Blood | 2867 / 13831 (20.7%) | 10818 / 138310 (7.8%) | −324.0 | −324.0 | 2.65 |
| Ep300 SRX183951 | Th1 Cells Blood | 2381 / 13831 (17.2%) | 9005 / 138310 (6.5%) | −324.0 | −324.0 | 2.64 |
| Kdm1a SRX3660772 | CD4 CD8 double negative cells Blood | 2861 / 13831 (20.7%) | 10873 / 138310 (7.9%) | −324.0 | −324.0 | 2.63 |
| Smarca4 SRX8693963 | Neutrophils Blood | 2372 / 13831 (17.1%) | 9051 / 138310 (6.5%) | −324.0 | −324.0 | 2.62 |
| Hdac2 SRX3660760 | CD4 CD8 double negative cells Blood | 3137 / 13831 (22.7%) | 12059 / 138310 (8.7%) | −324.0 | −324.0 | 2.60 |
| Runx3 SRX7554476 | CD8+ T cells Blood | 2417 / 13831 (17.5%) | 9304 / 138310 (6.7%) | −324.0 | −324.0 | 2.60 |
| Spi1 SRX2341958 | Granulocytic-monocytic progenitors Blood | 2272 / 13831 (16.4%) | 8748 / 138310 (6.3%) | −324.0 | −324.0 | 2.60 |
| Runx1 SRX3660777 | Bone Marrow Cells Blood | 2530 / 13831 (18.3%) | 9759 / 138310 (7.1%) | −324.0 | −324.0 | 2.59 |
| Chd4 SRX3660754 | Bone Marrow Cells Blood | 2507 / 13831 (18.1%) | 9737 / 138310 (7.0%) | −324.0 | −324.0 | 2.57 |
| Sin3a SRX188800 | MEL Blood | 2517 / 13831 (18.2%) | 9851 / 138310 (7.1%) | −324.0 | −324.0 | 2.56 |
| Spi1 SRX2341959 | Granulocytic-monocytic progenitors Blood | 2365 / 13831 (17.1%) | 9344 / 138310 (6.8%) | −324.0 | −324.0 | 2.53 |
| Spi1 SRX7368539 | B cells Blood | 2892 / 13831 (20.9%) | 11714 / 138310 (8.5%) | −324.0 | −324.0 | 2.47 |
| Smarcc1 SRX8673311 | Tumor Others | 2659 / 13831 (19.2%) | 10829 / 138310 (7.8%) | −324.0 | −324.0 | 2.46 |
| Epitope tags SRX6370146 | G1E Blood | 2592 / 13831 (18.7%) | 10673 / 138310 (7.7%) | −324.0 | −324.0 | 2.43 |
| Spi1 SRX2499685 | CD25+ cells Blood | 2711 / 13831 (19.6%) | 11187 / 138310 (8.1%) | −324.0 | −324.0 | 2.42 |
| Ctcf SRX10095027 | Bone Marrow Cells Blood | 3556 / 13831 (25.7%) | 14695 / 138310 (10.6%) | −324.0 | −324.0 | 2.42 |
| Spi1 SRX310205 | Mast Cells Blood | 3296 / 13831 (23.8%) | 13721 / 138310 (9.9%) | −324.0 | −324.0 | 2.40 |
| Kdm1a SRX3660773 | Bone Marrow Cells Blood | 2788 / 13831 (20.2%) | 11608 / 138310 (8.4%) | −324.0 | −324.0 | 2.40 |
| Kdm1a SRX3660774 | Bone Marrow Cells Blood | 2909 / 13831 (21.0%) | 12239 / 138310 (8.8%) | −324.0 | −324.0 | 2.38 |
| Runx1 SRX3660778 | Bone Marrow Cells Blood | 2987 / 13831 (21.6%) | 12700 / 138310 (9.2%) | −324.0 | −324.0 | 2.35 |
| Epitope tags SRX6370144 | G1E Blood | 2754 / 13831 (19.9%) | 11712 / 138310 (8.5%) | −324.0 | −324.0 | 2.35 |
| Spi1 SRX1939448 | Lymphoid-primed multipotent progenitors Blood | 3059 / 13831 (22.1%) | 13050 / 138310 (9.4%) | −324.0 | −324.0 | 2.34 |
| Spi1 SRX7821062 | Hematopoietic progenitors Blood | 3057 / 13831 (22.1%) | 13051 / 138310 (9.4%) | −324.0 | −324.0 | 2.34 |
| Epitope tags SRX6370142 | G1E Blood | 2726 / 13831 (19.7%) | 11659 / 138310 (8.4%) | −324.0 | −324.0 | 2.34 |
| Hdac2 SRX3660762 | Bone Marrow Cells Blood | 2975 / 13831 (21.5%) | 12733 / 138310 (9.2%) | −324.0 | −324.0 | 2.34 |
| Hdac2 SRX3660761 | Bone Marrow Cells Blood | 2874 / 13831 (20.8%) | 12534 / 138310 (9.1%) | −324.0 | −324.0 | 2.29 |
| Epitope tags SRX6370143 | G1E Blood | 3023 / 13831 (21.9%) | 13455 / 138310 (9.7%) | −324.0 | −324.0 | 2.25 |
| Nfib SRX19694892 | C3H/10T1/2 Embryonic fibroblast | 2139 / 13831 (15.5%) | 7954 / 138310 (5.8%) | −323.3 | −321.4 | 2.69 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 876 / 13831 (6.3%) | 1392 / 138310 (1.0%) | −322.5 | −320.7 | 6.29 |
| Spi1 SRX1131940 | Plasmablasts Blood | 1774 / 13831 (12.8%) | 5779 / 138310 (4.2%) | −322.5 | −320.6 | 3.07 |
| Max SRX9432515 | RAW 264.7 Blood | 1890 / 13831 (13.7%) | 6453 / 138310 (4.7%) | −322.5 | −320.6 | 2.93 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 1740 / 13831 (12.6%) | 5585 / 138310 (4.0%) | −322.4 | −320.5 | 3.12 |
| Nipbl SRX5730168 | B cells Blood | 1137 / 13831 (8.2%) | 2485 / 138310 (1.8%) | −321.7 | −319.8 | 4.58 |
| Epitope tags SRX3219125 | RN2 Blood | 1369 / 13831 (9.9%) | 3601 / 138310 (2.6%) | −321.3 | −319.5 | 3.80 |
| Spi1 SRX7692793 | Eosinophils Blood | 1656 / 13831 (12.0%) | 5127 / 138310 (3.7%) | −321.2 | −319.4 | 3.23 |
| Nipbl SRX8694066 | B cells Blood | 1485 / 13831 (10.7%) | 4204 / 138310 (3.0%) | −320.9 | −319.1 | 3.53 |
| Brd4 SRX8934799 | B cells Blood | 1029 / 13831 (7.4%) | 2017 / 138310 (1.5%) | −320.9 | −319.0 | 5.10 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1098 / 13831 (7.9%) | 2318 / 138310 (1.7%) | −320.7 | −318.8 | 4.74 |
| Biotin SRX10950530 | Pro-B cells Blood | 1440 / 13831 (10.4%) | 3976 / 138310 (2.9%) | −320.2 | −318.4 | 3.62 |
| Spi1 SRX5026211 | Mast Cells Blood | 1468 / 13831 (10.6%) | 4126 / 138310 (3.0%) | −319.9 | −318.0 | 3.56 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1557 / 13831 (11.3%) | 4604 / 138310 (3.3%) | −319.5 | −317.7 | 3.38 |
| Kdm1a SRX181863 | Granulocytes Blood | 1463 / 13831 (10.6%) | 4110 / 138310 (3.0%) | −318.9 | −317.0 | 3.56 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 1982 / 13831 (14.3%) | 7055 / 138310 (5.1%) | −318.5 | −316.6 | 2.81 |
| Hdac1 SRX1815526 | B cells Blood | 1201 / 13831 (8.7%) | 2809 / 138310 (2.0%) | −318.3 | −316.4 | 4.28 |
| Fli1 SRX1056338 | 416B Blood | 1203 / 13831 (8.7%) | 2827 / 138310 (2.0%) | −317.3 | −315.4 | 4.26 |
| Stat5a SRX17605414 | Leukemia Blood | 1657 / 13831 (12.0%) | 5182 / 138310 (3.7%) | −317.1 | −315.3 | 3.20 |
| Brd4 SRX8379041 | Macrophages Blood | 1654 / 13831 (12.0%) | 5169 / 138310 (3.7%) | −316.8 | −315.0 | 3.20 |
| Nipbl SRX5730167 | B cells Blood | 1423 / 13831 (10.3%) | 3928 / 138310 (2.8%) | −316.4 | −314.5 | 3.62 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 1747 / 13831 (12.6%) | 5711 / 138310 (4.1%) | −315.6 | −313.8 | 3.06 |
| Runx2 SRX17733007 | ATDC-5 Pluripotent stem cell | 2339 / 13831 (16.9%) | 9341 / 138310 (6.8%) | −315.4 | −313.6 | 2.50 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 1763 / 13831 (12.7%) | 5812 / 138310 (4.2%) | −314.9 | −313.1 | 3.03 |
| Runx1 DRX165596 | Unclassified Unclassified | 1268 / 13831 (9.2%) | 3162 / 138310 (2.3%) | −314.8 | −312.9 | 4.01 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 1930 / 13831 (14.0%) | 6800 / 138310 (4.9%) | −314.6 | −312.7 | 2.84 |
| Med23 SRX20509321 | CH12 Blood | 1344 / 13831 (9.7%) | 3554 / 138310 (2.6%) | −313.3 | −311.5 | 3.78 |
| Wdr5 SRX1815515 | B cells Blood | 1547 / 13831 (11.2%) | 4630 / 138310 (3.3%) | −312.5 | −310.6 | 3.34 |
| Ep300 SRX7726459 | Natural killer cells Blood | 1724 / 13831 (12.5%) | 5630 / 138310 (4.1%) | −311.6 | −309.7 | 3.06 |
| Nipbl SRX8694070 | B cells Blood | 1295 / 13831 (9.4%) | 3329 / 138310 (2.4%) | −311.2 | −309.3 | 3.89 |
| Runx1 SRX7821112 | Hematopoietic progenitors Blood | 1015 / 13831 (7.3%) | 2034 / 138310 (1.5%) | −310.2 | −308.4 | 4.99 |
| Brd4 SRX884070 | MLL-AF9 leukemic cell Blood | 1508 / 13831 (10.9%) | 4446 / 138310 (3.2%) | −310.1 | −308.2 | 3.39 |
| Kat2a SRX1815524 | B cells Blood | 1210 / 13831 (8.7%) | 2924 / 138310 (2.1%) | −310.1 | −308.2 | 4.14 |
| Runx1 SRX1939447 | Lymphoid-primed multipotent progenitors Blood | 1014 / 13831 (7.3%) | 2032 / 138310 (1.5%) | −309.9 | −308.1 | 4.99 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1406 / 13831 (10.2%) | 3908 / 138310 (2.8%) | −309.8 | −308.0 | 3.60 |
| Rad21 SRX2755282 | B cells Blood | 2324 / 13831 (16.8%) | 9345 / 138310 (6.8%) | −309.5 | −307.7 | 2.49 |
| Brd4 SRX8379040 | Macrophages Blood | 1632 / 13831 (11.8%) | 5138 / 138310 (3.7%) | −309.3 | −307.4 | 3.18 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 1835 / 13831 (13.3%) | 6311 / 138310 (4.6%) | −309.0 | −307.2 | 2.91 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1396 / 13831 (10.1%) | 3865 / 138310 (2.8%) | −309.0 | −307.1 | 3.61 |
| Fli1 SRX884086 | MLL-AF9 leukemic cell Blood | 2833 / 13831 (20.5%) | 12794 / 138310 (9.3%) | −308.9 | −307.1 | 2.21 |
| Chd4 SRX1815509 | B cells Blood | 1792 / 13831 (13.0%) | 6065 / 138310 (4.4%) | −308.5 | −306.7 | 2.95 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 1772 / 13831 (12.8%) | 5952 / 138310 (4.3%) | −308.2 | −306.4 | 2.98 |
| Nipbl SRX8694068 | B cells Blood | 1297 / 13831 (9.4%) | 3381 / 138310 (2.4%) | −306.8 | −305.0 | 3.84 |
| Nipbl SRX8694071 | B cells Blood | 1195 / 13831 (8.6%) | 2882 / 138310 (2.1%) | −306.7 | −304.9 | 4.15 |
| Tmem131 SRX3219121 | RN2 Blood | 1280 / 13831 (9.3%) | 3299 / 138310 (2.4%) | −306.5 | −304.7 | 3.88 |
| Kmt2a SRX22719786 | Leukemia Blood | 1332 / 13831 (9.6%) | 3566 / 138310 (2.6%) | −306.0 | −304.2 | 3.74 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 1816 / 13831 (13.1%) | 6242 / 138310 (4.5%) | −305.7 | −303.9 | 2.91 |
| Kmt2a SRX25655413 | Leukemia Blood | 1338 / 13831 (9.7%) | 3603 / 138310 (2.6%) | −305.4 | −303.6 | 3.71 |
| Runx2 SRX17733008 | ATDC-5 Pluripotent stem cell | 2196 / 13831 (15.9%) | 8590 / 138310 (6.2%) | −305.3 | −303.4 | 2.56 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1359 / 13831 (9.8%) | 3714 / 138310 (2.7%) | −305.1 | −303.3 | 3.66 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1364 / 13831 (9.9%) | 3742 / 138310 (2.7%) | −304.9 | −303.0 | 3.65 |
| Nipbl SRX3753614 | B cells Blood | 1459 / 13831 (10.5%) | 4250 / 138310 (3.1%) | −304.1 | −302.3 | 3.43 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 996 / 13831 (7.2%) | 2000 / 138310 (1.4%) | −303.7 | −301.9 | 4.98 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 1788 / 13831 (12.9%) | 6105 / 138310 (4.4%) | −303.7 | −301.9 | 2.93 |
| Spi1 SRX2341952 | LSK cells Blood | 1653 / 13831 (12.0%) | 5328 / 138310 (3.9%) | −303.5 | −301.7 | 3.10 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 807 / 13831 (5.8%) | 1249 / 138310 (0.9%) | −302.5 | −300.7 | 6.46 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1091 / 13831 (7.9%) | 2434 / 138310 (1.8%) | −302.1 | −300.3 | 4.48 |
| Spi1 SRX12298594 | B cells Blood | 1830 / 13831 (13.2%) | 6379 / 138310 (4.6%) | −301.9 | −300.1 | 2.87 |
| Phf8 SRX2396657 | Prostate Prostate | 1910 / 13831 (13.8%) | 6868 / 138310 (5.0%) | −301.4 | −299.6 | 2.78 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1153 / 13831 (8.3%) | 2731 / 138310 (2.0%) | −301.2 | −299.4 | 4.22 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1525 / 13831 (11.0%) | 4644 / 138310 (3.4%) | −300.9 | −299.1 | 3.28 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1226 / 13831 (8.9%) | 3091 / 138310 (2.2%) | −300.3 | −298.5 | 3.97 |
| Rad21 SRX7481994 | Pro-B cells Blood | 1812 / 13831 (13.1%) | 6302 / 138310 (4.6%) | −299.7 | −297.9 | 2.88 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 869 / 13831 (6.3%) | 1508 / 138310 (1.1%) | −298.9 | −297.1 | 5.76 |
| Fli1 SRX884087 | MLL-AF9 leukemic cell Blood | 3131 / 13831 (22.6%) | 15142 / 138310 (10.9%) | −298.4 | −296.6 | 2.07 |
| Runx1 SRX1901620 | G1E Blood | 1420 / 13831 (10.3%) | 4107 / 138310 (3.0%) | −298.2 | −296.4 | 3.46 |
| Irf4 SRX2162564 | Pre-B cells Blood | 2338 / 13831 (16.9%) | 9639 / 138310 (7.0%) | −297.7 | −295.9 | 2.43 |
| Hcfc1 SRX22599848 | NIH/3T3 Embryonic fibroblast | 519 / 13831 (3.8%) | 373 / 138310 (0.3%) | −297.5 | −295.7 | 13.91 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1668 / 13831 (12.1%) | 5490 / 138310 (4.0%) | −297.5 | −295.7 | 3.04 |
| Spi1 SRX2997922 | Hematopoietic Stem Cells Blood | 2945 / 13831 (21.3%) | 13821 / 138310 (10.0%) | −297.4 | −295.6 | 2.13 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1368 / 13831 (9.9%) | 3842 / 138310 (2.8%) | −297.3 | −295.5 | 3.56 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1367 / 13831 (9.9%) | 3838 / 138310 (2.8%) | −297.2 | −295.4 | 3.56 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1509 / 13831 (10.9%) | 4600 / 138310 (3.3%) | −297.2 | −295.4 | 3.28 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 1810 / 13831 (13.1%) | 6327 / 138310 (4.6%) | −297.1 | −295.3 | 2.86 |
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 579 / 13831 (4.2%) | 535 / 138310 (0.4%) | −295.7 | −293.9 | 10.82 |
| Hcfc1 SRX188798 | MEL Blood | 1643 / 13831 (11.9%) | 5372 / 138310 (3.9%) | −295.6 | −293.8 | 3.06 |
| Pax5 SRX5358487 | Pro-B cells Blood | 1672 / 13831 (12.1%) | 5537 / 138310 (4.0%) | −295.5 | −293.7 | 3.02 |
| Spi1 SRX2980171 | Myeloid leukemia Blood | 2463 / 13831 (17.8%) | 10514 / 138310 (7.6%) | −295.4 | −293.6 | 2.34 |
| Nelfa SRX6714137 | Heart Cardiovascular | 2111 / 13831 (15.3%) | 8211 / 138310 (5.9%) | −295.2 | −293.4 | 2.57 |
| Phf8 SRX2396659 | Prostate Prostate | 1803 / 13831 (13.0%) | 6313 / 138310 (4.6%) | −295.1 | −293.3 | 2.86 |
| Kdm2b SRX22719878 | Leukemia Blood | 1663 / 13831 (12.0%) | 5498 / 138310 (4.0%) | −294.7 | −292.9 | 3.02 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 999 / 13831 (7.2%) | 2082 / 138310 (1.5%) | −294.5 | −292.7 | 4.80 |
| Kmt2a SRX11002576 | Leukemia Blood | 1089 / 13831 (7.9%) | 2489 / 138310 (1.8%) | −294.4 | −292.6 | 4.38 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1494 / 13831 (10.8%) | 4554 / 138310 (3.3%) | −294.1 | −292.3 | 3.28 |
| Smc1a SRX7348141 | Thymocytes Blood | 1876 / 13831 (13.6%) | 6771 / 138310 (4.9%) | −293.8 | −292.0 | 2.77 |
| AML1-ETO SRX3491901 | Spleen Spleen | 1910 / 13831 (13.8%) | 6978 / 138310 (5.0%) | −293.7 | −291.9 | 2.74 |
| Erg SRX884089 | MLL-AF9 leukemic cell Blood | 3258 / 13831 (23.6%) | 16191 / 138310 (11.7%) | −293.3 | −291.5 | 2.01 |
| Spi1 SRX2997920 | Hematopoietic Stem Cells Blood | 3019 / 13831 (21.8%) | 14447 / 138310 (10.4%) | −293.0 | −291.2 | 2.09 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 882 / 13831 (6.4%) | 1598 / 138310 (1.2%) | −293.0 | −291.2 | 5.52 |
| Smc1a SRX7348142 | Thymocytes Blood | 1850 / 13831 (13.4%) | 6634 / 138310 (4.8%) | −292.3 | −290.6 | 2.79 |
| Ep300 SRX1565831 | Natural killer cells Blood | 1835 / 13831 (13.3%) | 6544 / 138310 (4.7%) | −292.2 | −290.5 | 2.80 |
| Spi1 SRX8030788 | Acute myeloid leukemia Blood | 1925 / 13831 (13.9%) | 7097 / 138310 (5.1%) | −292.1 | −290.3 | 2.71 |
| Tcf3 SRX1568859 | B cells Blood | 1488 / 13831 (10.8%) | 4547 / 138310 (3.3%) | −291.9 | −290.1 | 3.27 |
| Eomes SRX4510927 | OT-1 Blood | 1916 / 13831 (13.9%) | 7045 / 138310 (5.1%) | −291.7 | −289.9 | 2.72 |
| Spi1 SRX2997919 | Hematopoietic Stem Cells Blood | 2887 / 13831 (20.9%) | 13528 / 138310 (9.8%) | −291.5 | −289.7 | 2.13 |
| Ikzf1 SRX149203 | B3 Blood | 989 / 13831 (7.2%) | 2061 / 138310 (1.5%) | −291.5 | −289.7 | 4.80 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 1737 / 13831 (12.6%) | 5983 / 138310 (4.3%) | −290.7 | −288.9 | 2.90 |
| Foxp3 SRX2341414 | Treg Blood | 1699 / 13831 (12.3%) | 5761 / 138310 (4.2%) | −290.5 | −288.7 | 2.95 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1211 / 13831 (8.8%) | 3111 / 138310 (2.2%) | −290.4 | −288.7 | 3.89 |
| Foxp3 SRX2341417 | Treg Blood | 1647 / 13831 (11.9%) | 5463 / 138310 (3.9%) | −290.3 | −288.6 | 3.01 |
| Ikzf1 SRX8994274 | B cells Blood | 849 / 13831 (6.1%) | 1484 / 138310 (1.1%) | −290.2 | −288.4 | 5.72 |
| Spi1 SRX8693957 | Neutrophils Blood | 2049 / 13831 (14.8%) | 7908 / 138310 (5.7%) | −289.6 | −287.9 | 2.59 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 1772 / 13831 (12.8%) | 6206 / 138310 (4.5%) | −289.5 | −287.8 | 2.86 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 806 / 13831 (5.8%) | 1332 / 138310 (1.0%) | −287.6 | −285.8 | 6.05 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 1711 / 13831 (12.4%) | 5873 / 138310 (4.2%) | −287.6 | −285.8 | 2.91 |
| Brd4 SRX10701687 | Spleen Spleen | 1169 / 13831 (8.5%) | 2933 / 138310 (2.1%) | −287.4 | −285.6 | 3.99 |
| Ep300 SRX1565832 | Natural killer cells Blood | 1746 / 13831 (12.6%) | 6085 / 138310 (4.4%) | −287.2 | −285.4 | 2.87 |
| Nr3c1 SRX4615043 | Lung endothelial cells Cardiovascular | 2312 / 13831 (16.7%) | 9655 / 138310 (7.0%) | −287.1 | −285.3 | 2.39 |
| Hcfc1 SRX188815 | CH12 Blood | 1754 / 13831 (12.7%) | 6143 / 138310 (4.4%) | −286.3 | −284.5 | 2.86 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1505 / 13831 (10.9%) | 4712 / 138310 (3.4%) | −286.0 | −284.2 | 3.19 |
| Runx1 SRX1892671 | 416B Blood | 1362 / 13831 (9.8%) | 3939 / 138310 (2.8%) | −285.5 | −283.7 | 3.46 |
| Spi1 SRX5026212 | Mast Cells Blood | 1307 / 13831 (9.4%) | 3650 / 138310 (2.6%) | −285.4 | −283.7 | 3.58 |
| Elf1 SRX12734919 | Granulocyte-Macrophage Progenitor Cells Blood | 1203 / 13831 (8.7%) | 3120 / 138310 (2.3%) | −285.4 | −283.6 | 3.86 |
| Spi1 SRX2499689 | CD25+ cells Blood | 1486 / 13831 (10.7%) | 4615 / 138310 (3.3%) | −285.3 | −283.5 | 3.22 |
| Spi1 SRX5026213 | Mast Cells Blood | 1268 / 13831 (9.2%) | 3459 / 138310 (2.5%) | −284.4 | −282.6 | 3.67 |
| Ep300 SRX8379017 | Macrophages Blood | 2261 / 13831 (16.3%) | 9375 / 138310 (6.8%) | −283.9 | −282.1 | 2.41 |
| Med1 SRX1403505 | MLL-AF9 leukemic cell Blood | 1833 / 13831 (13.3%) | 6663 / 138310 (4.8%) | −283.4 | −281.6 | 2.75 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1145 / 13831 (8.3%) | 2862 / 138310 (2.1%) | −282.4 | −280.7 | 4.00 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1610 / 13831 (11.6%) | 5353 / 138310 (3.9%) | −282.4 | −280.6 | 3.01 |
| Spi1 SRX2997921 | Hematopoietic Stem Cells Blood | 2668 / 13831 (19.3%) | 12187 / 138310 (8.8%) | −281.6 | −279.8 | 2.19 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1291 / 13831 (9.3%) | 3608 / 138310 (2.6%) | −281.5 | −279.8 | 3.58 |
| Runx3 SRX338019 | Natural killer cells Blood | 955 / 13831 (6.9%) | 1989 / 138310 (1.4%) | −281.3 | −279.6 | 4.80 |
| Biotin SRX13366572 | Plasmablasts Blood | 1711 / 13831 (12.4%) | 5963 / 138310 (4.3%) | −281.0 | −279.3 | 2.87 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 811 / 13831 (5.9%) | 1392 / 138310 (1.0%) | −281.0 | −279.3 | 5.83 |
| Batf SRX10150718 | CD8+ T cells Blood | 1457 / 13831 (10.5%) | 4513 / 138310 (3.3%) | −280.4 | −278.7 | 3.23 |
| Med12 SRX5086065 | Th2 Cells Blood | 966 / 13831 (7.0%) | 2053 / 138310 (1.5%) | −279.3 | −277.6 | 4.71 |
| Rag2 SRX018807 | Thymocytes Blood | 885 / 13831 (6.4%) | 1704 / 138310 (1.2%) | −279.2 | −277.5 | 5.19 |
| Ep300 SRX8379016 | Macrophages Blood | 2186 / 13831 (15.8%) | 8966 / 138310 (6.5%) | −279.0 | −277.3 | 2.44 |
| Tcf3 SRX1568865 | Unclassified Unclassified | 1174 / 13831 (8.5%) | 3042 / 138310 (2.2%) | −278.5 | −276.8 | 3.86 |
| Bcl11a SRX8030787 | Acute myeloid leukemia Blood | 998 / 13831 (7.2%) | 2205 / 138310 (1.6%) | −278.3 | −276.6 | 4.53 |
| Spi1 SRX2997918 | Hematopoietic Stem Cells Blood | 2824 / 13831 (20.4%) | 13385 / 138310 (9.7%) | −277.2 | −275.4 | 2.11 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1347 / 13831 (9.7%) | 3952 / 138310 (2.9%) | −277.1 | −275.4 | 3.41 |
| Nelfa SRX6714136 | Heart Cardiovascular | 2157 / 13831 (15.6%) | 8810 / 138310 (6.4%) | −277.1 | −275.4 | 2.45 |
| Nr1d1 SRX24603399 | Hepa 1-6 Liver | 2496 / 13831 (18.0%) | 11085 / 138310 (8.0%) | −277.0 | −275.3 | 2.25 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1388 / 13831 (10.0%) | 4198 / 138310 (3.0%) | −275.0 | −273.3 | 3.31 |
| Tet2 SRX1387481 | MEL Blood | 1238 / 13831 (9.0%) | 3403 / 138310 (2.5%) | −274.9 | −273.2 | 3.64 |
| Pax5 SRX7809233 | Pro-B cells Blood | 1266 / 13831 (9.2%) | 3551 / 138310 (2.6%) | −274.6 | −272.9 | 3.57 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1301 / 13831 (9.4%) | 3738 / 138310 (2.7%) | −274.3 | −272.6 | 3.48 |
| Nr3c1 SRX4615040 | Lung endothelial cells Cardiovascular | 2366 / 13831 (17.1%) | 10251 / 138310 (7.4%) | −274.3 | −272.6 | 2.31 |
| Kmt2a SRX17605409 | Monocytes Blood | 1408 / 13831 (10.2%) | 4319 / 138310 (3.1%) | −274.0 | −272.3 | 3.26 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 741 / 13831 (5.4%) | 1167 / 138310 (0.8%) | −273.8 | −272.1 | 6.35 |
| Irf4 SRX1131942 | Plasmablasts Blood | 1208 / 13831 (8.7%) | 3281 / 138310 (2.4%) | −271.8 | −270.1 | 3.68 |
| Ep300 SRX183950 | Th1 Cells Blood | 2158 / 13831 (15.6%) | 8930 / 138310 (6.5%) | −270.5 | −268.8 | 2.42 |
| Rad21 SRX3753624 | B cells Blood | 2499 / 13831 (18.1%) | 11254 / 138310 (8.1%) | −269.5 | −267.8 | 2.22 |
| Runx1 SRX1892679 | 416B Blood | 1394 / 13831 (10.1%) | 4299 / 138310 (3.1%) | −269.2 | −267.5 | 3.24 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1478 / 13831 (10.7%) | 4769 / 138310 (3.4%) | −269.2 | −267.5 | 3.10 |
| Batf SRX10150717 | CD8+ T cells Blood | 1465 / 13831 (10.6%) | 4697 / 138310 (3.4%) | −269.1 | −267.4 | 3.12 |
| Kmt2a SRX25655410 | Leukemia Blood | 1260 / 13831 (9.1%) | 3581 / 138310 (2.6%) | −268.9 | −267.2 | 3.52 |
| Spi1 SRX5056010 | Hematopoietic progenitors Blood | 1637 / 13831 (11.8%) | 5694 / 138310 (4.1%) | −268.9 | −267.2 | 2.87 |
| Spi1 SRX1630944 | Granulocytic-monocytic progenitors Blood | 2041 / 13831 (14.8%) | 8200 / 138310 (5.9%) | −268.8 | −267.1 | 2.49 |
| Myc SRX353782 | B cells Blood | 1021 / 13831 (7.4%) | 2391 / 138310 (1.7%) | −268.8 | −267.1 | 4.27 |
| Rad21 SRX7508562 | Pro-B cells Blood | 1150 / 13831 (8.3%) | 3027 / 138310 (2.2%) | −267.8 | −266.1 | 3.80 |
| Kdm1a SRX5056006 | Hematopoietic progenitors Blood | 2512 / 13831 (18.2%) | 11387 / 138310 (8.2%) | −267.4 | −265.7 | 2.21 |
| Kmt2a SRX25655412 | Leukemia Blood | 1181 / 13831 (8.5%) | 3188 / 138310 (2.3%) | −267.4 | −265.7 | 3.70 |
| Spi1 SRX2499694 | Scid.adh.2c2 Blood | 1190 / 13831 (8.6%) | 3234 / 138310 (2.3%) | −267.4 | −265.7 | 3.68 |
| Ascl1 SRX8886262 | Lung tumors Lung | 1884 / 13831 (13.6%) | 7231 / 138310 (5.2%) | −266.9 | −265.2 | 2.61 |
| Kmt2a SRX25655409 | Leukemia Blood | 1195 / 13831 (8.6%) | 3266 / 138310 (2.4%) | −266.8 | −265.1 | 3.66 |
| Nipbl SRX8693945 | Neutrophils Blood | 1866 / 13831 (13.5%) | 7123 / 138310 (5.2%) | −266.6 | −264.9 | 2.62 |
| Spi1 SRX1686485 | Bone Marrow Cells Blood | 1443 / 13831 (10.4%) | 4605 / 138310 (3.3%) | −266.5 | −264.8 | 3.13 |
| Nr1d1 SRX24603398 | Hepa 1-6 Liver | 2367 / 13831 (17.1%) | 10424 / 138310 (7.5%) | −265.5 | −263.8 | 2.27 |
| Spi1 SRX2997917 | Hematopoietic Stem Cells Blood | 2654 / 13831 (19.2%) | 12426 / 138310 (9.0%) | −265.3 | −263.6 | 2.14 |
| Sp1 SRX7799921 | CH12 Blood | 1636 / 13831 (11.8%) | 5745 / 138310 (4.2%) | −264.9 | −263.2 | 2.85 |
| Med12 SRX5086064 | Th2 Cells Blood | 918 / 13831 (6.6%) | 1954 / 138310 (1.4%) | −264.7 | −263.0 | 4.70 |
| Nelfb SRX11921266 | Naive T cells Blood | 1060 / 13831 (7.7%) | 2613 / 138310 (1.9%) | −264.7 | −263.0 | 4.06 |
| Kdm2b SRX22719874 | Leukemia Blood | 1391 / 13831 (10.1%) | 4338 / 138310 (3.1%) | −264.6 | −263.0 | 3.21 |
| Biotin SRX273254 | B cells Blood | 2604 / 13831 (18.8%) | 12089 / 138310 (8.7%) | −264.5 | −262.8 | 2.15 |
| Zfp384 SRX2324494 | Spermatogonia Gonad | 2037 / 13831 (14.7%) | 8248 / 138310 (6.0%) | −264.4 | −262.7 | 2.47 |
| Spi1 SRX340955 | FDCPmix Blood | 1431 / 13831 (10.3%) | 4566 / 138310 (3.3%) | −264.3 | −262.6 | 3.13 |
| Zfp384 SRX2324495 | Spermatogonia Gonad | 1842 / 13831 (13.3%) | 7014 / 138310 (5.1%) | −264.0 | −262.3 | 2.63 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1197 / 13831 (8.7%) | 3306 / 138310 (2.4%) | −263.9 | −262.2 | 3.62 |
| Nipbl SRX13845192 | Scid.adh.2c2 Blood | 863 / 13831 (6.2%) | 1724 / 138310 (1.2%) | −263.4 | −261.8 | 5.01 |
| Relb SRX20904785 | Dendritic Cells Blood | 2872 / 13831 (20.8%) | 14033 / 138310 (10.1%) | −263.4 | −261.8 | 2.05 |
| Kdm4b SRX7794503 | Mesenchymal stem cells Others | 1320 / 13831 (9.5%) | 3975 / 138310 (2.9%) | −262.4 | −260.7 | 3.32 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 785 / 13831 (5.7%) | 1408 / 138310 (1.0%) | −262.3 | −260.6 | 5.58 |
| Kmt2d SRX17605389 | Granulocytic-monocytic progenitors Blood | 1576 / 13831 (11.4%) | 5426 / 138310 (3.9%) | −262.2 | −260.5 | 2.90 |
| Men1 SRX415268 | Th2 Cells Blood | 1035 / 13831 (7.5%) | 2516 / 138310 (1.8%) | −262.2 | −260.5 | 4.11 |
| Spi1 SRX742829 | Plasmacytoid dendritic cells Blood | 1802 / 13831 (13.0%) | 6795 / 138310 (4.9%) | −262.1 | −260.4 | 2.65 |
| Phf8 SRX2396660 | Prostate Prostate | 1984 / 13831 (14.3%) | 7962 / 138310 (5.8%) | −261.2 | −259.5 | 2.49 |
| Biotin SRX13366571 | Plasmablasts Blood | 1530 / 13831 (11.1%) | 5176 / 138310 (3.7%) | −260.9 | −259.2 | 2.96 |
| Fli1 SRX203227 | Megakaryocytes Blood | 1371 / 13831 (9.9%) | 4274 / 138310 (3.1%) | −260.8 | −259.1 | 3.21 |
| Spi1 SRX884085 | MLL-AF9 leukemic cell Blood | 3578 / 13831 (25.9%) | 19427 / 138310 (14.0%) | −260.7 | −259.0 | 1.84 |
| Cbfb SRX105447 | L8057 Blood | 1283 / 13831 (9.3%) | 3797 / 138310 (2.7%) | −260.5 | −258.8 | 3.38 |
| Nipbl SRX8693944 | Neutrophils Blood | 1876 / 13831 (13.6%) | 7283 / 138310 (5.3%) | −260.4 | −258.7 | 2.58 |
| Spi1 SRX3723674 | Neutrophils Blood | 2033 / 13831 (14.7%) | 8292 / 138310 (6.0%) | −260.4 | −258.7 | 2.45 |
| Med1 SRX1403504 | MLL-AF9 leukemic cell Blood | 1421 / 13831 (10.3%) | 4567 / 138310 (3.3%) | −259.7 | −258.0 | 3.11 |
| Tet2 SRX4232706 | Hematopoietic cells Blood | 1125 / 13831 (8.1%) | 2985 / 138310 (2.2%) | −259.4 | −257.7 | 3.77 |
| Bcl11b SRX663233 | Thymocytes Blood | 1509 / 13831 (10.9%) | 5075 / 138310 (3.7%) | −259.3 | −257.7 | 2.97 |
| Spi1 SRX884084 | MLL-AF9 leukemic cell Blood | 2586 / 13831 (18.7%) | 12077 / 138310 (8.7%) | −259.2 | −257.5 | 2.14 |
| Ep300 SRX7726474 | Natural killer cells Blood | 1086 / 13831 (7.9%) | 2793 / 138310 (2.0%) | −259.1 | −257.4 | 3.89 |
| Phf8 SRX2396658 | Prostate Prostate | 1920 / 13831 (13.9%) | 7586 / 138310 (5.5%) | −259.0 | −257.3 | 2.53 |
| Spi1 SRX5026209 | Mast Cells Blood | 1101 / 13831 (8.0%) | 2869 / 138310 (2.1%) | −259.0 | −257.3 | 3.84 |
| Spi1 SRX2499720 | Scid.adh.2c2 Blood | 1334 / 13831 (9.6%) | 4093 / 138310 (3.0%) | −258.9 | −257.2 | 3.26 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1382 / 13831 (10.0%) | 4362 / 138310 (3.2%) | −258.6 | −256.9 | 3.17 |
| Ikzf1 SRX20340936 | Pre-B cells Blood | 1423 / 13831 (10.3%) | 4594 / 138310 (3.3%) | −258.5 | −256.8 | 3.10 |
| Spi1 SRX2980172 | Myeloid leukemia Blood | 2061 / 13831 (14.9%) | 8509 / 138310 (6.2%) | −258.4 | −256.8 | 2.42 |
| Kmt2a SRX17605408 | Monocytes Blood | 1269 / 13831 (9.2%) | 3747 / 138310 (2.7%) | −258.3 | −256.6 | 3.39 |
| Ikzf1 SRX149204 | B3 Blood | 869 / 13831 (6.3%) | 1789 / 138310 (1.3%) | −258.2 | −256.5 | 4.86 |
| Phf8 SRX15939565 | NIH/3T3 Embryonic fibroblast | 1120 / 13831 (8.1%) | 2973 / 138310 (2.1%) | −258.1 | −256.4 | 3.77 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1337 / 13831 (9.7%) | 4120 / 138310 (3.0%) | −258.0 | −256.3 | 3.25 |
Showing first 500 of 10640 rows.